Lumentum Stock Was Already Sold Out Before Its Big Rally

Before the stock took off, the company was repeatedly telling anyone who would listen that it simply could not make its AI-enabling components fast enough.

When a stock puts up a 769% return in a year, the natural question is: how? What catalyst, what surprise, could justify a move that big? For Lumentum (LITE), the answer was predictable, coming from a story the company had been telling for months—a clear signal of a fundamental mismatch between what the world wanted and what Lumentum could supply.

The evidence was the headline itself. Management was, in essence, telling Wall Street they were sold out.

How Far Back Did The “Sold Out” Warnings Go?

This wasn’t a one-quarter phenomenon. The drumbeat had been building. On its earnings call in February 2025, months before the surge began, management was direct. They stated they anticipated that “demand for our EML chips will continue to exceed supply at least into calendar year 2026.” This amounted to a declaration of a long-term shortage.

Go back even further, to November 2024, and the message was the same. The company expected to be on “allocation throughout calendar year 2025.” For a component supplier, being on allocation is the commercial equivalent of a hot nightclub with a line around the block. It means you can’t satisfy all your customers, and you have to decide who gets the product. It’s a high-class problem that often precedes a major repricing of a stock.

What Was Causing The Shortage?

The driver was the one force reshaping the entire market: artificial intelligence. The CEO, on the May 2025 call, cited the “immense cloud and AI opportunity” as the reason he’d joined the company. Lumentum’s specialized indium phosphide lasers and chips were the critical plumbing for the new generation of AI data centers.

The demand was showing up in the numbers. The company’s Cloud & Networking segment revenue grew 16% year-over-year in its fiscal third quarter of 2025, and it had just set another “record for EML chip set shipments.” The financial turn was already underway, substantiating the talk. As of that same quarter, trailing-twelve-month revenue growth had accelerated to 3.6%, a notable reversal from its three-year average decline of 3.4%. The question of whether AI’s rapid growth could hit a supply ceiling is a recurring theme for investors, and Lumentum was living it.

Was The Options Market Braced For This?

Here’s the twist. While management was openly discussing a supply crunch, the options market seemed to be looking the other way. In the weeks leading up to the July 2025 takeoff, implied volatility on Lumentum stock actually eased from the 71st percentile of its one-year range down to a sleepy 17th percentile. Traders, in other words, were pricing in a period of relative calm, not the significant repricing that was just around the corner. The story was hiding in plain sight, but not everyone was reading the script.

This was the sound of a bottleneck in the AI revolution, and Lumentum was holding the keys.

And if it is exposure to Nasdaq as a whole you want, rather than hunting the next single name to surge, a Nasdaq ETF like QQEW covers that broad index.

Catching The Move Is Not The Same As Keeping It

Spotting a setup before it runs is a real edge – but a name you are excited about has a way of becoming an oversized part of your portfolio, and the same volatility that powers a surge can reverse it. Concentration turns that reversal into real damage, and selling to trim it triggers a tax bill. There is a way to lock in the gains and diversify without the tax hit.